SCOPUS 정보 검색 플랫폼

OncoImmunology

Volumn 3, Issue 7, 2014, Pages

Leveraging chemotherapy-induced lymphopenia to potentiate cancer immunotherapy

(5) Sanchez Perez, Luis a Suryadevara, Carter M a,b Choi, Bryan D c Reap, Elizabeth A a Sampson, John H a,b

a DUKE UNIVERSITY MEDICAL CENTER (United States)

b DUKE UNIVERSITY SCHOOL OF MEDICINE (United States)

c MASSACHUSETTS GENERAL HOSPITAL (United States)

Author keywords

Chemotherapy; Glioblastoma; Immunotherapy; Lymphopenia; Temozolomide

Indexed keywords

B CELL ACTIVATING FACTOR; CANCER VACCINE; CISPLATIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DOCETAXEL; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR; FLUDARABINE; FLUOROURACIL; GEMCITABINE; INTERFERON; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 7; PACLITAXEL; PATTERN RECOGNITION RECEPTOR; PEPTIDE VACCINE; TEMOZOLOMIDE;

ADOPTIVE TRANSFER; ANTIGEN PRESENTING CELL; ARTICLE; CANCER CHEMOTHERAPY; CANCER IMMUNIZATION; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CELLULAR IMMUNITY; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; DRUG POTENTIATION; DRUG SAFETY; EXTERNAL BEAM RADIOTHERAPY; GLIOBLASTOMA; HUMAN; IMMUNOMODULATION; LYMPHOCYTOPENIA; MELANOMA; MOLECULARLY TARGETED THERAPY; NON SMALL CELL LUNG CANCER; NONHUMAN; OVERALL SURVIVAL; PATIENT SAFETY; PROGRESSION FREE SURVIVAL; REGULATORY T LYMPHOCYTE; SURVIVAL TIME; T CELL DEPLETION;

EID: 84911401432 PISSN: 21624011 EISSN: 2162402X Source Type: Journal
DOI: 10.4161/21624011.2014.944054 Document Type: Article

Times cited : (20)

References (10)

1
- 20044366163
- Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
- PMID: 15758009
- Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. New Engl J Med 2005; 352:987-96; PMID: 15758009; http://dx.doi.org/10.1056/NEJMoa043330
- (2005) New Engl J Med , vol.352 , pp. 987-996
- Stupp, R.¹ Mason, W.P.² Van Den Bent, M.J.³ Weller, M.⁴ Fisher, B.⁵ Taphoorn, M.J.⁶ Belanger, K.⁷ Brandes, A.A.⁸ Marosi, C.⁹ Bogdahn, U.¹⁰

2
- 84878892458
- BLyS levels correlate with vaccine-induced antibody titers in patients with glioblastoma lymphodepleted by therapeutic temozolomide
- Sanchez-Perez L, Choi BD, Reap EA, Sayour EJ, Norberg P, Schmittling RJ, Archer GE, Herndon II JE, Mitchell DA, Heimberger AB, et al. BLyS levels correlate with vaccine-induced antibody titers in patients with glioblastoma lymphodepleted by therapeutic temozolomide. Cancer Immunol Immun 2013; 62:983-7; http://dx.doi.org/10.1007/s00262-013-1405-y
- (2013) Cancer Immunol Immun , vol.62 , pp. 983-987
- Sanchez-Perez, L.¹ Choi, B.D.² Reap, E.A.³ Sayour, E.J.⁴ Norberg, P.⁵ Schmittling, R.J.⁶ Archer, G.E.⁷ Herndon II, J.E.⁸ Mitchell, D.A.⁹ Heimberger, A.B.¹⁰

3
- 84875068031
- Myeloablative temozolomide enhances CD8(+) T-cell responses to vaccine and is required for efficacy against brain tumors in mice
- PMID: 23527092
- Sanchez-Perez LA, Choi BD, Archer GE, Cui X, Flores C, Johnson LA, Schmittling RJ, Snyder D, Herndon II JE, Bigner DD, et al. Myeloablative temozolomide enhances CD8(+) T-cell responses to vaccine and is required for efficacy against brain tumors in mice. PloS One 2013; 8:e59082; PMID: 23527092; http://dx.doi.org/10.1371/journal. pone.0059082
- (2013) PloS One , vol.8
- Sanchez-Perez, L.A.¹ Choi, B.D.² Archer, G.E.³ Cui, X.⁴ Flores, C.⁵ Johnson, L.A.⁶ Schmittling, R.J.⁷ Snyder, D.⁸ Herndon II, J.E.⁹ Bigner, D.D.¹⁰

4
- 41149097574
- Adoptive cell transfer: a clinical path to effective cancer immunotherapy
- PMID: 18354418
- Rosenberg SA, Restifo NP, Yang JC, Morgan RA, Dudley ME. Adoptive cell transfer: a clinical path to effective cancer immunotherapy. Nat Rev Cancer 2008; 8:299-308; PMID: 18354418; http://dx.doi. org/10.1038/nrc2355
- (2008) Nat Rev Cancer , vol.8 , pp. 299-308
- Rosenberg, S.A.¹ Restifo, N.P.² Yang, J.C.³ Morgan, R.A.⁴ Dudley, M.E.⁵

5
- 84880747672
- Mechanism of action of conventional and targeted anticancer therapies: reinstating immunosurveillance
- PMID: 23890065
- Zitvogel L, Galluzzi L, Smyth MJ, Kroemer G. Mechanism of action of conventional and targeted anticancer therapies: reinstating immunosurveillance. Immunity 2013; 39:74-88; PMID: 23890065; http://dx.doi.org/10.1016/j.immuni.2013.06.014
- (2013) Immunity , vol.39 , pp. 74-88
- Zitvogel, L.¹ Galluzzi, L.² Smyth, M.J.³ Kroemer, G.⁴

6
- 79955784386
- Greater chemotherapy- induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIIIexpressing tumor cells in patients with glioblastoma
- PMID: 21149254;
- Sampson JH, Aldape KD, Archer GE, Coan A, Desjardins A, Friedman AH, Friedman HS, Gilbert MR, Herndon JE, McLendon RE, et al. Greater chemotherapy- induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIIIexpressing tumor cells in patients with glioblastoma. Neuro-Oncol 2011; 13:324-33; PMID: 21149254; http://dx.doi.org/10.1093/neuonc/noq157
- (2011) Neuro-Oncol , vol.13 , pp. 324-333
- Sampson, J.H.¹ Aldape, K.D.² Archer, G.E.³ Coan, A.⁴ Desjardins, A.⁵ Friedman, A.H.⁶ Friedman, H.S.⁷ Gilbert, M.R.⁸ Herndon, J.E.⁹ McLendon, R.E.¹⁰

7
- 84857547272
- A pilot study of IL-2Ralpha blockade during lymphopenia depletes regulatory T-cells and correlates with enhanced immunity in patients with glioblastoma
- PMID: 22383993
- Sampson JH, Schmittling RJ, Archer GE, Congdon KL, Nair SK, Reap EA, Desjardins A, Friedman AH, Friedman HS, Herndon II JE, et al. A pilot study of IL-2Ralpha blockade during lymphopenia depletes regulatory T-cells and correlates with enhanced immunity in patients with glioblastoma. PloS One 2012; 7:e31046; PMID: 22383993; http://dx.doi. org/10.1371/journal.pone.0031046
- (2012) PloS One , vol.7
- Sampson, J.H.¹ Schmittling, R.J.² Archer, G.E.³ Congdon, K.L.⁴ Nair, S.K.⁵ Reap, E.A.⁶ Desjardins, A.⁷ Friedman, A.H.⁸ Friedman, H.S.⁹ Herndon II, J.E.¹⁰

8
- 80052919974
- Monoclonal antibody blockade of IL-2 receptor alpha during lymphopenia selectively depletes regulatory T cells in mice and humans
- PMID: 21768296
- Mitchell DA, Cui X, Schmittling RJ, Sanchez-Perez L, Snyder DJ, Congdon KL, Archer GE, Desjardins A, Friedman AH, Friedman HS, et al. Monoclonal antibody blockade of IL-2 receptor alpha during lymphopenia selectively depletes regulatory T cells in mice and humans. Blood 2011; 118:3003-12; PMID: 21768296; http://dx.doi.org/10.1182/blood- 2011-02-334565
- (2011) Blood , vol.118 , pp. 3003-3012
- Mitchell, D.A.¹ Cui, X.² Schmittling, R.J.³ Sanchez-Perez, L.⁴ Snyder, D.J.⁵ Congdon, K.L.⁶ Archer, G.E.⁷ Desjardins, A.⁸ Friedman, A.H.⁹ Friedman, H.S.¹⁰

9
- 81255127285
- Therapeutic vaccination with TG4010 and first-line chemotherapy in advanced non-small-cell lung cancer: a controlled phase 2B trial
- PMID: 22019520
- Quoix E, Ramlau R, Westeel V, Papai Z, Madroszyk A, Riviere A, Koralewski P, Breton JL, Stoelben E, Braun D, et al. Therapeutic vaccination with TG4010 and first-line chemotherapy in advanced non-small-cell lung cancer: a controlled phase 2B trial. Lancet Oncol 2011; 12:1125-33; PMID: 22019520; http://dx.doi.org/10.1016/S1470-2045 (11)70259-5
- (2011) Lancet Oncol , vol.12 , pp. 1125-1133
- Quoix, E.¹ Ramlau, R.² Westeel, V.³ Papai, Z.⁴ Madroszyk, A.⁵ Riviere, A.⁶ Koralewski, P.⁷ Breton, J.L.⁸ Stoelben, E.⁹ Braun, D.¹⁰

10
- 58149376993
- Chemotherapy enhances vaccine-induced antitumor immunity in melanoma patients
- PMID: 18839429
- Nistico P, Capone I, Palermo B, Del Bello D, Ferraresi V, Moschella F, Arico E, Valentini M, Bracci L, Cognetti F, et al. Chemotherapy enhances vaccine-induced antitumor immunity in melanoma patients. Int J Cancer J Inter du Cancer 2009; 124:130-9; PMID: 18839429; http://dx.doi.org/10.1002/ijc.23886
- (2009) Int J Cancer J Inter du Cancer , vol.124 , pp. 130-139
- Nistico, P.¹ Capone, I.² Palermo, B.³ Del Bello, D.⁴ Ferraresi, V.⁵ Moschella, F.⁶ Arico, E.⁷ Valentini, M.⁸ Bracci, L.⁹ Cognetti, F.¹⁰

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.